Manchon M, Verdier M F, Pallud P, Vialle A, Beseme F, Bienvenu J
J Anal Toxicol. 1985 Sep-Oct;9(5):209-12. doi: 10.1093/jat/9.5.209.
The EMIT-TOX Enzyme Immunoassay for benzodiazepines was evaluated. Reproducibility, linearity, accuracy, sensitivity, and interferences were tested and found to be in good agreement with the manufacturer's specifications. Furthermore, the reactivity of 15 benzodiazepines were studied. According their differential reactivity, the 15 benzodiazepines can be classified into three groups: good reactivity similar to diazepam (potassium clorazepate, prazepam, estazolam, medazepam, flunitrazepam, nitrazepam); medium reactivity (clobazam, clonazepam, bromazepam, chlordiazepoxide, triazolam); and low reactivity (oxazepam, ethyl loflazepate, lorazepam). A possible structure/reactivity relationship is discussed. It is concluded that this kit is well adapted for the rapid detection of most benzodiazepines, but in no way can the EMIT technique permit quantitative results without clinical information.
对用于检测苯二氮䓬类药物的EMIT - TOX酶免疫测定法进行了评估。测试了其重现性、线性、准确性、灵敏度和干扰情况,发现与制造商的规格高度相符。此外,还研究了15种苯二氮䓬类药物的反应活性。根据它们不同的反应活性,这15种苯二氮䓬类药物可分为三组:反应活性良好,与地西泮类似(氯氮䓬钾、普拉西泮、艾司唑仑、美达西泮、氟硝西泮、硝西泮);中等反应活性(氯巴占、氯硝西泮、溴西泮、氯氮䓬、三唑仑);以及低反应活性(奥沙西泮、卤沙唑仑乙酯、劳拉西泮)。文中讨论了可能的结构/反应活性关系。得出的结论是,该试剂盒非常适合快速检测大多数苯二氮䓬类药物,但如果没有临床信息,EMIT技术绝不可能得出定量结果。